Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1131138 | 0.91 | TDP1 (0.58) | TDP1LMNAMAPK1SLC6A2ALDH1A1 | |
| SCHEMBL2978166 | 0.90 | TDP1 (0.61) | TDP1LMNAMAPK1HIF1ASLC6A2 | |
| SCHEMBL15865271 | 0.90 | TDP1 (0.56) | TDP1LMNAMAPK1SLC6A2ALDH1A1 | |
| SCHEMBL218011 | 0.89 | TDP1 (0.56) | TDP1LMNASMN1; SMN2TSHR | |
| SCHEMBL16684723 | 0.89 | TDP1 (0.56) | TDP1LMNAMAPK1ALDH1A1SMN1; SMN2 | |
| SCHEMBL15865003 | 0.88 | TDP1 (0.53) | TDP1LMNAMAPK1SLC6A2SLC6A3 | |
| SCHEMBL2192154 | 0.88 | TDP1 (0.56) | TDP1LMNAKMT2ACNR2 | |
| SCHEMBL29975539 | 0.88 | TDP1 (0.56) | TDP1LMNAKMT2ACNR2 | |
| SCHEMBL12879054 | 0.87 | TDP1 (0.54) | TDP1LMNAKMT2ASMN1; SMN2 | |
| SCHEMBL223441 | 0.86 | TDP1 (1.00) | TDP1LMNAMAPK1HIF1ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 444 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100242790-A1 | CATIONICALLY AND HYBRID CURABLE UV GELS | XEROX CORPORATION (US) | 2010-09-30 | — | — | US | claimed |
| EP-2233541-A1 | Cationically and hybrid curable UV gels | Xerox Corporation (US) | 2010-09-29 | — | — | EP | claimed |
| EP-0861453-A1 | MATRIX COMPOUNDS FOR FORMING OPTICAL FIBER RIBBONS | Lightguide Materials, Inc. (US) | 1998-09-02 | — | — | EP | claimed |
| WO-1997018493-A1 | MATRIX COMPOUNDS FOR FORMING OPTICAL FIBER RIBBONS | LIGHTGUIDE MATERIALS, INC. (US) | 1997-05-22 | — | — | WO | claimed |
| EP-4565378-B1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2026-05-06 | — | — | EP | disclosed |
| US-12616995-B2 | Methods for producing overt security features exhibiting one or more indicia | SICPA HOLDING SA (CH) | 2026-05-05 | — | — | US | disclosed |
| EP-4352175-B1 | HYBRID UV-LED RADIATION CURABLE PROTECTIVE VARNISHES FOR SECURITY DOCUMENTS | SICPA HOLDING SA (CH) | 2026-02-25 | — | — | EP | disclosed |
| US-12535735-B2 | Modified thioxanthone photoinitiators | LINTFIELD LIMITED (GB) | 2026-01-27 | — | — | US | disclosed |
| US-20260015799-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2026-01-15 | — | — | US | disclosed |
| US-12515470-B2 | UV-Vis radiation curable security inks | SICPA HOLDING SA (CH) | 2026-01-06 | — | — | US | disclosed |
| EP-4433547-B1 | METHODS FOR PRODUCING OVERT SECURITY FEATURES EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2025-12-24 | — | — | EP | disclosed |
| US-12398152-B2 | Thioxanthone derivatives, composition comprising the same and pattern forming method comprising said composition | LINTFIELD LIMITED (GB) | 2025-08-26 | — | — | US | disclosed |
| WO-1997018493-A1 | MATRIX COMPOUNDS FOR FORMING OPTICAL FIBER RIBBONS | LIGHTGUIDE MATERIALS, INC. (US) | 1997-05-22 | — | — | WO | disclosed |
| EP-0549588-B1 | VINYL ETHER BASED OPTICAL FIBER COATINGS | ALLIED SIGNAL INC (US) | 1995-08-16 | — | — | EP | disclosed |
| EP-0483750-B1 | Fluorine-containing copolymer and curable composition containing the same | DAIKIN IND LTD (JP) | 1994-10-05 | — | — | EP | disclosed |
| EP-0549588-A1 | VINYL ETHER BASED OPTICAL FIBER COATINGS. | ALLIED SIGNAL INC (US) | 1993-07-07 | — | — | EP | disclosed |
| US-5142011-A | Films, coatings, sealants; solvent solubility, gloss, weatherability | DAIKIN INDUSTRIES, LTD. (JP) | 1992-08-25 | — | — | US | disclosed |
| US-5139872-A | Polyetherurethanes and polyesterurethanes endcapped with hydroxyvinyl ethers reacted with vinyl ether terminated ester or vinyl ether | ALLIED-SIGNAL INC. (US) | 1992-08-18 | — | — | US | disclosed |
| EP-0483750-A1 | Fluorine-containing copolymer and curable composition containing the same | DAIKIN INDUSTRIES, LIMITED (JP) | 1992-05-06 | — | — | EP | disclosed |
| WO-1992004388-A1 | VINYL ETHER BASED OPTICAL FIBER COATINGS | ALLIED-SIGNAL INC. (US) | 1992-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12398152-B2 | Thioxanthone derivatives, composition comprising the same and pattern forming method comprising said composition | TPMT, TST, PPOX | TDP1 235/4885LMNA 1218/4885MAPK1 4870/4885 |
| US-12535735-B2 | Modified thioxanthone photoinitiators | FTO, UGT1A6, TPMT | TDP1 1322/4885LMNA 1247/4885MAPK1 2495/4885 |
| US-20260015799-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | IK, TEX10, INCENP | TDP1 1958/4885LMNA 77/4885MAPK1 1758/4885 |
| US-12616995-B2 | Methods for producing overt security features exhibiting one or more indicia | ATG4B, TPM4, ATG4A | TDP1 2099/4885LMNA 1850/4885MAPK1 3659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.